PROTEOSTASIS THERAPEUTICS IN's ticker is PTI and the CUSIP is 74373B109. A total of 64 filers reported holding PROTEOSTASIS THERAPEUTICS IN in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $6,000 | -62.5% | 4,823 | 0.0% | 0.00% | – |
| Q4 2018 | $16,000 | +33.3% | 4,823 | 0.0% | 0.00% | – |
| Q3 2018 | $12,000 | -99.7% | 4,823 | -99.4% | 0.00% | – |
| Q1 2018 | $3,805,000 | -23.9% | 800,967 | -6.6% | 0.00% | -100.0% |
| Q4 2017 | $4,999,000 | +177.3% | 857,500 | -0.1% | 0.00% | – |
| Q3 2017 | $1,803,000 | -86.9% | 858,340 | -70.9% | 0.00% | -100.0% |
| Q2 2017 | $13,782,000 | -38.8% | 2,944,915 | +2.3% | 0.00% | -33.3% |
| Q1 2017 | $22,513,000 | -16.8% | 2,878,804 | +30.4% | 0.00% | -25.0% |
| Q4 2016 | $27,056,000 | -25.0% | 2,206,868 | -4.6% | 0.00% | -20.0% |
| Q3 2016 | $36,083,000 | +58.4% | 2,314,468 | +23.3% | 0.01% | +66.7% |
| Q2 2016 | $22,778,000 | +25.8% | 1,877,812 | 0.0% | 0.00% | 0.0% |
| Q1 2016 | $18,102,000 | – | 1,877,812 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HARBOURVEST PARTNERS LLC | 440,627 | $2,093,000 | 2.25% |
| NEA Management Company, LLC | 5,556,778 | $26,395,000 | 1.17% |
| Endurant Capital Management LP | 472,012 | $2,242,000 | 0.84% |
| DAFNA Capital Management LLC | 267,100 | $1,269,000 | 0.62% |
| RTW INVESTMENTS, LP | 1,104,940 | $5,248,000 | 0.50% |
| DOHENY ASSET MANAGEMENT /CA | 69,625 | $331,000 | 0.17% |
| BAILARD, INC. | 520,100 | $2,470,000 | 0.16% |
| Bain Capital Public Equity Management, LLC | 399,947 | $1,900,000 | 0.14% |
| Rock Springs Capital Management LP | 675,000 | $3,206,000 | 0.14% |
| Hillhouse Capital Management | 865,923 | $4,113,000 | 0.07% |